Raderer, Markus <br/><br/>
Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.  [electronic resource] 

 -  Oncology  2003 
 - 306-10 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0030-2414 
<br/><br/><label>Standard No.: </label>10.1159/000074641  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--immunology<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antigens, CD20--drug effects<br/>Antineoplastic Agents--immunology<br/>Epitopes, B-Lymphocyte--drug effects<br/>Female<br/>Humans<br/>Immunotherapy--methods<br/>Lymphoma, B-Cell, Marginal Zone--drug therapy<br/>Male<br/>Retrospective Studies<br/>Rituximab